rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Andrew Jacob Silver

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, CRISPR Therapeutics AG.

Every Form 4 they filed

In numbers

Trades disclosed
1
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
19 Oct 2026
Last trade
19 Oct 2026
Last filed
21 Oct 2026

Companies traded

Where they are an officer
CRSP CRISPR Therapeutics AGOfficer · Genomics & Gene Editing · last 19 Oct 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
19 Oct 2026filed 21 Oct 2026CRSP CRISPR Therapeutics AGoption or derivative · Genomics & Gene EditingSEC FORM 4 Code A—25,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Samarth KulkarniChief Executive Officer · Chief Executive Officer at CRISPR Therapeutics AG, filing Form 4 there in the last year
Simeon GeorgeDirector · Director at CRISPR Therapeutics AG, filing Form 4 there in the last year
James R. KasingerGeneral Counsel and Secretary · General Counsel and Secretary at CRISPR Therapeutics AG, filing Form 4 there in the last year
Ali BehbahaniDirector · Director at CRISPR Therapeutics AG, filing Form 4 there in the last year
Raju PrasadChief Financial Officer · Chief Financial Officer at CRISPR Therapeutics AG, filing Form 4 there in the last year